hydromorphone has been researched along with Cancer Pain in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (59.09) | 24.3611 |
| 2020's | 9 (40.91) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuda, Y; Niki, K; Okamoto, Y; Omae, T; Takagi, T; Takemura, M; Ueda, M | 1 |
| Chen, H; Huang, C; Li, X; Lin, R; Lin, S; Liu, J; Lu, M; Luo, Y; Lv, X; Su, L; Wu, M; Zhang, Z; Zhao, S; Zhou, M; Zhu, J; Zou, H | 1 |
| Dräger, DL | 1 |
| Arakawa, S; Chiu, SW; Hiratsuka, Y; Hirayama, H; Inoue, A; Ishiki, H; Kosugi, K; Kubo, E; Matsuda, Y; Miyashita, M; Morita, T; Natsume, M; Nishijima, K; Ouchi, K; Sato, M; Satomi, E; Shigeno, T; Shimizu, M; Shimoda, M; Shimoi, T; Tagami, K; Yamaguchi, T; Yokomichi, N | 1 |
| Bao, HG; Chen, FQ; Duan, BL; Feng, ZY; Huang, YQ; Jin, Y; Liu, YQ; Lu, Y; Ma, K; Song, T; Wang, K; Wang, L; Xie, GL; Xu, JT; Yang, XQ | 1 |
| Mercadante, S | 1 |
| Cai, Z; Chen, Y; Feng, S; Fu, J; Hong, L; Huang, C; Lai, T; Li, H; Li, X; Lin, G; Lin, R; Lin, S; Lin, Y; Lv, X; Wang, F; Wang, J; Wu, Q; Xin, M; Yang, S; Yao, Y; Zhang, G; Zhao, S; Zhu, J | 1 |
| Dong, S; Dou, Z; Knaggs, R; Li, Y; Lu, G; Ma, J; Xia, J; Yang, L; Zhao, S | 1 |
| Bell, RF; Derry, S; Moore, RA; Wee, B; Wiffen, PJ | 1 |
| Azhar, A; Baumgartner, K; Bruera, E; Dost, S; Heung, Y; Kwan, S; Lim, KH; Liu, D; Nguyen, A; Pangemanan, I; Reddy, A; Rodriguez, E; Stephen, S; Tayjasanant, S; Vidal, M; Waletich, J; Williams, J; Wong, A; Wu, J; Yennurajalingam, S | 1 |
| Bayer, O; Heid, F; Laufenberg-Feldmann, R; Schuster, M | 1 |
| Aruga, E; Inoue, S; Saito, Y; Takahashi, H; Tsuneto, S; Uemori, M | 1 |
| Feng, Z; Guo, J; Guo, X; Peng, Z; Zhang, Y | 1 |
| Adaramola, D; Ibrahim, AM; Obaidi, Z; Onguti, S; Ruan, G | 1 |
| Han, FY; Howdle, SM; Naylor, A; Shabir-Ahmed, A; Smith, MT; Whittaker, A | 1 |
| Ammar, D; Baron, L; Chvetzoff, G; Collin, E; Delorme, C; Delorme, T; Faure, S; Filbet, M; Hubault, P; Jovenin, N; Krakowski, I; Magnet, M; Michenot, N; Minello, C; Poulain, P; Rostaing, S | 1 |
| Aner, M; Petro, J; Urits, I; Viswanath, O | 1 |
| Brás, M; Fragoso, M; Vieira, C | 1 |
| Brogan, SE; Jackman, CM; Okifuji, A; Sindt, JE; White, J; Wilding, V | 1 |
| Arthur, JA; Bruera, E; Haider, A; Hui, D; Liu, D; Park, M; Reddy, A; Smith, U; Vaughan-Adams, N; Williams, J | 1 |
| Flory, JH; Koranteng, L; Moryl, N; Thaler, HT; Wiesenthal, AC | 1 |
| Ahn, SJ; Choi, YJ; Kang, HW; Kim, TO; Kim, YC; Kim, YK; Lee, MK; Na, KJ; Oh, IJ; Park, CK; Song, GA | 1 |
5 review(s) available for hydromorphone and Cancer Pain
| Article | Year |
|---|---|
Hydromorphone for cancer pain.
Topics: Adult; Analgesics, Opioid; Cancer Pain; Child; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Oxycodone | 2021 |
Opioids for cancer pain - an overview of Cochrane reviews.
Topics: Acetaminophen; Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Fentanyl; Humans; Hydromorphone; Methadone; Oxycodone; Phenols; Review Literature as Topic; Tapentadol; Tramadol | 2017 |
Opioid Rotation in Cancer Pain Treatment.
Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Chronic Pain; Fentanyl; Germany; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain Management | 2018 |
[Opioid switch and change of route of administration in cancer patients treated by morphine].
Topics: Administration, Oral; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Drug Substitution; Fentanyl; France; Humans; Hydromorphone; Injections, Intravenous; Injections, Subcutaneous; Methadone; Morphine; Oxycodone; Phenols; Tapentadol | 2018 |
[Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review].
Topics: Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Deglutition Disorders; Fentanyl; Humans; Hydromorphone; Liver Failure; Morphine; Oxycodone; Renal Dialysis; Renal Insufficiency; Tapentadol; Tramadol | 2019 |
4 trial(s) available for hydromorphone and Cancer Pain
| Article | Year |
|---|---|
Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Humans; Hydromorphone; Morphine; Neoplasms; Pain Measurement | 2022 |
Intrathecal delivery of hydromorphone vs morphine for refractory cancer pain: a multicenter, randomized, single-blind, controlled noninferiority trial.
Topics: Analgesics, Opioid; Cancer Pain; China; Double-Blind Method; Humans; Hydromorphone; Injections, Spinal; Morphine; Neoplasms; Pain, Postoperative; Single-Blind Method | 2020 |
Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Cancer Pain; Humans; Hydromorphone; Neoplasms; Pain | 2021 |
A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients.
Topics: Aged; Analgesics, Opioid; Asian People; Cancer Pain; Delayed-Action Preparations; Demography; Depression; Double-Blind Method; Female; Humans; Hydromorphone; Japan; Male; Neoplasms; Oxycodone; Pain Measurement; Powders; Tablets; Treatment Outcome | 2018 |
13 other study(ies) available for hydromorphone and Cancer Pain
| Article | Year |
|---|---|
Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Hydromorphone; Japan; Male; Methadone; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Retrospective Studies; Tapentadol | 2021 |
[Drug therapy for cancer-related pain-evidence regarding hydromorphone, oxycodone, and methadone : Presentation and summary of three Cochrane reviews].
Topics: Analgesics, Opioid; Cancer Pain; Humans; Hydromorphone; Methadone; Neoplasms; Oxycodone | 2023 |
Prevalence of opioid-induced adverse events across opioids commonly used for analgesic treatment in Japan: a multicenter prospective longitudinal study.
Topics: Analgesics, Opioid; Cancer Pain; Constipation; Delirium; Fentanyl; Humans; Hydromorphone; Japan; Longitudinal Studies; Nausea; Oxycodone; Prevalence; Prospective Studies; Tramadol; Vomiting | 2023 |
Intrathecal patient-controlled analgesia has nothing to do with breakthrough cancer pain.
Topics: Analgesia, Epidural; Analgesia, Patient-Controlled; Breakthrough Pain; Cancer Pain; Humans; Hydromorphone; Morphine; Neoplasms; Single-Blind Method | 2021 |
The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Drug Dosage Calculations; Female; Humans; Hydromorphone; Linear Models; Male; Middle Aged; Morphine; Oxycodone; Palliative Care; Patient Discharge; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Patient-Controlled Intravenous Analgesia for Advanced Cancer Patients with Pain: A Retrospective Series Study.
Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Cancer Pain; Female; Humans; Hydromorphone; Male; Middle Aged; Oxycodone; Pain Management; Patient Satisfaction; Retrospective Studies; Sufentanil | 2018 |
Nalbuphine for Opioid-Induced Urine Retention.
Topics: Abdominal Pain; Analgesics, Opioid; Cancer Pain; Carcinoma, Renal Cell; Hospice Care; Humans; Hydromorphone; Kidney Neoplasms; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Nalbuphine; Portal Vein; Urinary Retention; Venous Thrombosis | 2018 |
Sustained-Release Hydromorphone Microparticles Produced by Supercritical Fluid Polymer Encapsulation.
Topics: Analgesics, Opioid; Cancer Pain; Delayed-Action Preparations; Drug Compounding; Drug Liberation; Humans; Hydromorphone; Injections, Spinal; Polylactic Acid-Polyglycolic Acid Copolymer | 2019 |
Retrograde placement of an intrathecal catheter for chronic low pelvic cancer pain.
Topics: Bupivacaine; Cancer Pain; Catheterization; Chronic Pain; Colonic Neoplasms; Fluoroscopy; Humans; Hydromorphone; Infusion Pumps, Implantable; Infusions, Spinal; Male; Middle Aged; Pain Management; Spine; Treatment Outcome | 2019 |
Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Constipation; Female; Humans; Hydromorphone; Injections, Spinal; Male; Middle Aged; Neoplasms; Pain Measurement; Pain, Postoperative; Prospective Studies; Treatment Outcome; Young Adult | 2020 |
Practices and perceptions regarding intravenous opioid infusion and cancer pain management.
Topics: Adult; Analgesics, Opioid; Cancer Pain; Clinical Competence; Cross-Sectional Studies; Female; Fentanyl; Humans; Hydromorphone; Infusions, Intravenous; Male; Middle Aged; Morphine; Neoplasms; Nurses; Pain Management; Surveys and Questionnaires; Time Factors | 2019 |
Methadone Use and the Risk of Hypoglycemia for Inpatients With Cancer Pain.
Topics: Adult; Aged; Analgesics, Opioid; Blood Glucose; Cancer Pain; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Hypoglycemia; Incidence; Inpatients; Male; Methadone; Middle Aged; Retrospective Studies; Risk; Time Factors | 2016 |
Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study.
Topics: Aged; Analgesics, Opioid; Cancer Pain; Constipation; Dizziness; Drug Administration Schedule; Female; Humans; Hydromorphone; Male; Middle Aged; Nausea; Pain Management; Patient Satisfaction; Prospective Studies; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome | 2016 |